Ferreira-Gonzalez Andrea, Shiffman Mitchell L
Division of Molecular Diagnostics, Department of Pathology, Virginia Commonwealth University Medical Center, Richmond, Virginia 23298, USA.
Semin Liver Dis. 2004;24 Suppl 2:9-18. doi: 10.1055/s-2004-832923.
Serological and virological testing for the hepatitis C virus (HCV) is essential in the management of patients with chronic HCV infection. Recent advances in molecular virology tests and the development of a new international unit standard have greatly simplified the use and interpretation of these tests. In the absence of treatment, baseline serum HCV RNA does not change over time and does not correlate with the severity of hepatic inflammation or fibrosis on liver biopsy. In contrast, changes in serum HCV RNA level are important predictors of virological response to treatment with pegylated interferon and ribavirin.
丙型肝炎病毒(HCV)的血清学和病毒学检测对于慢性HCV感染患者的管理至关重要。分子病毒学检测的最新进展以及新国际单位标准的制定极大地简化了这些检测的使用和解读。在未接受治疗的情况下,基线血清HCV RNA不会随时间变化,且与肝活检时肝脏炎症或纤维化的严重程度无关。相比之下,血清HCV RNA水平的变化是聚乙二醇化干扰素和利巴韦林治疗病毒学应答的重要预测指标。